True Wealth Design’s Cidara Therapeutics CDTX Stock Holding History

True Wealth Design’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14	Closed	-$3.09K	–	2721
2025 Q4	$3.09K	Buy	14 +9	+180%	+$1.46K	﹤0.01%	1283
2025 Q3	$479	Buy	+5	New	+$319	﹤0.01%	2020

True Wealth Design's CDTX Position: Q1 2026 in Review

True Wealth Design sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 14 shares — an estimated $3.09K sold.

True Wealth Design first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $3.09K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

True Wealth Design reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
True Wealth Design sold 14 Cidara Therapeutics shares in Q1 2026, an estimated $3.09K.
True Wealth Design first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
True Wealth Design's Cidara Therapeutics position peaked at $3.09K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on True Wealth Design's 13F filing for Q1 2026, filed 13 Apr 2026.